Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDbluebird bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$11.70 | -$5.55 | -$8.82 |
| Q2 2024 | 4 | -$11.06 | -$5.25 | -$8.33 |
| Q3 2024 | 1 | -$9.66 | -$4.58 | -$7.28 |
| Q4 2024 | 3 | -$6.85 | -$4.43 | -$5.97 |
| Q1 2025 | 3 | -$4.61 | -$1.68 | -$3.36 |
| Q2 2025 | 2 | -$2.30 | -$1.09 | -$1.73 |
| Q3 2025 | 2 | -$0.40 | -$0.19 | -$0.30 |
| Q4 2025 | 2 | $0.07 | $0.16 | $0.12 |
| Q1 2026 | 1 | $0.48 | $1.02 | $0.77 |
| Q2 2026 | 1 | $0.63 | $1.33 | $1.00 |
| Q3 2026 | 1 | $0.97 | $2.04 | $1.54 |
| Q4 2026 | 1 | $1.13 | $2.38 | $1.80 |
bluebird bio, Inc. Earnings Date And Information
bluebird bio, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-6.2 earnings per share for the quarter, topping analysts' consensus estimates of $-7.28 by $1.08. The company had revenue of 10.61 M for the quarter and had revenue of 29.50 M for the year. bluebird bio, Inc. has generated $-2 earnings per share over the last year ($-1.93 diluted earnings per share) and currently has a price-to-earnings ratio of -5.03. bluebird bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
bluebird bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$7.28 | -$0.31 | 6.97 | $18.05 M | $10.61 M |
| 09/27/2024 | Q2 2024 | -$0.42 | $24.25 M | $16.10 M | ||
| 09/13/2024 | Q1 2024 | -$0.40 | -$0.36 | 0.04 | $18.57 M | |
| 09/13/2024 | Q4 2023 | -$0.40 | -$0.75 | -0.35 | $7.83 M | |
| 11/07/2023 | Q3 2023 | -$0.69 | -$0.66 | 0.03 | $13.56 M | $12.39 M |
| 08/08/2023 | Q2 2023 | -$0.72 | -$0.67 | 0.05 | $11.30 M | $6.89 M |
| 05/09/2023 | Q1 2023 | -$0.54 | $0.33 | 0.87 | $2.38 M | |
| 03/29/2023 | Q4 2022 | -$0.45 | $0.38 | 0.83 | $62,000 | |
| 11/07/2022 | Q3 2022 | -$1.28 | -$0.94 | 0.34 | $1.07 M | $71,000 |
| 08/04/2022 | Q2 2022 | -$1.31 | -$1.26 | 0.05 | $824,167 | $1.52 M |
| 05/09/2022 | Q1 2022 | -$1.26 | -$1.68 | -0.42 | $1.95 M | |
| 03/04/2022 | Q4 2021 | -$1.82 | -$2.14 | -0.32 | $1.61 M | |
| 11/05/2021 | Q3 2021 | -$2.72 | -$3.16 | -0.44 | $37.21 M | $22.68 M |
| 08/09/2021 | Q2 2021 | -$3.26 | -$3.58 | -0.32 | $16.28 M | $7.47 M |
| 05/05/2021 | Q1 2021 | -$3.05 | -$3.07 | -0.02 | $12.79 M | |
| 02/23/2021 | Q4 2020 | -$3.02 | -$3.01 | 0.01 | $10.71 M | |
| 11/04/2020 | Q3 2020 | -$3.07 | -$2.94 | 0.13 | $24.32 M | $19.27 M |
| 08/05/2020 | Q2 2020 | -$1.91 | -$0.36 | 1.55 | $76.46 M | $198.89 M |
| 05/11/2020 | Q1 2020 | -$3.94 | -$3.64 | 0.3 | $21.86 M | |
| 02/18/2020 | Q4 2019 | -$3.81 | -$4.04 | -0.23 | $10.00 M |
bluebird bio, Inc. Earnings: FAQ's
When is bluebird bio, Inc.'s earnings date?
bluebird bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
Did bluebird bio, Inc. beat their earnings estimates last
quarter?
In the previous quarter, bluebird bio, Inc. (:BLUE) reported $-6.2 earnings per share (EPS) to beat the analysts' consensus estimate of $-7.28 by $1.08.
How can I listen to bluebird bio, Inc.'s earnings conference
call?
The conference call for bluebird bio, Inc.'s latest earnings report can be listened to online.
How can I read bluebird bio, Inc.'s conference call transcript?
The conference call transcript for bluebird bio, Inc.'s latest earnings report can be read online.
How much revenue does bluebird bio, Inc. generate each year?
bluebird bio, Inc. (:BLUE) has a recorded annual revenue of $29.50 M.
How much profit does bluebird bio, Inc. generate each year?
bluebird bio, Inc. (:BLUE) has a recorded net income of $29.50 M. bluebird bio, Inc. has generated $-1.93 earnings per share over the last four quarters.
What is bluebird bio, Inc.'s price-to-earnings ratio?
bluebird bio, Inc. (:BLUE) has a price-to-earnings ratio of -5.03 and price/earnings-to-growth ratio is -0.31.